Flc Capital Advisors Pfizer Inc Transaction History

Flc Capital Advisors

$430 Million
Q3 2024

A detailed history of Flc Capital Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Flc Capital Advisors holds 38,772 shares of PFE stock, worth $994,501. This represents 0.26% of its overall portfolio holdings.

Number of Shares

38,772

Previous 33,216 16.73%

Holding current value

$994,501

Previous $929,000 20.78%

% of portfolio

0.26%

Previous 0.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$27.7 - $31.39 $153,901 - $174,402	5,556 Added 16.73%	38,772 $1.12 Million
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $87,147 - $102,120	-3,450 Reduced 9.41%	33,216 $929,000
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $59,961 - $68,854	2,316 Added 6.74%	36,666 $1.02 Million
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $337,259 - $438,063	-12,907 Reduced 27.31%	34,350 $988,000
Q3 2023 Jan 18, 2024	SELL	$32.09 - $37.51 $238,685 - $278,999	-7,438 Reduced 13.6%	47,257 $1.57 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $137,544 - $159,136	-3,808 Reduced 6.51%	54,695 $2.01 Million
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $137,155 - $178,556	-3,482 Reduced 5.62%	58,503 $2.39 Million
Q4 2022 Jan 27, 2023	SELL	$41.75 - $54.5 $82,372 - $107,528	-1,973 Reduced 3.08%	61,985 $3.18 Million
Q3 2022 Oct 14, 2022	SELL	$43.76 - $53.42 $132,155 - $161,328	-3,020 Reduced 4.51%	63,958 $2.8 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $81,241 - $96,326	-1,746 Reduced 2.54%	66,978 $3.51 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $77,409 - $95,919	-1,692 Reduced 2.4%	68,724 $3.56 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $58,633 - $86,913	-1,419 Reduced 1.98%	70,416 $4.16 Million
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $89,529 - $115,008	-2,281 Reduced 3.08%	71,835 $3.09 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $3,267 - $3,701	-91 Reduced 0.12%	74,116 $2.9 Million
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $489,958 - $552,575	14,630 Added 24.56%	74,207 $2.69 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $324,357 - $412,448	9,691 Added 19.43%	59,577 $2.19 Million
Q3 2020 Oct 23, 2020	BUY	$31.75 - $37.25 $296,767 - $348,175	9,347 Added 23.06%	49,886 $1.87 Million
Q2 2020 Jul 10, 2020	BUY	$30.12 - $36.54 $194,364 - $235,792	6,453 Added 18.93%	40,539 $1.4 Million
Q1 2020 Apr 09, 2020	BUY	$27.03 - $38.62 $128,122 - $183,058	4,740 Added 16.15%	34,086 $1.12 Million
Q4 2019 Jan 13, 2020	SELL	$32.92 - $37.36 $2,699 - $3,063	-82 Reduced 0.28%	29,346 $1.15 Million
Q3 2019 Oct 29, 2019	BUY	$32.49 - $42.13 $30,118 - $39,054	927 Added 3.25%	29,428 $1.06 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $187,007 - $209,966	5,057 Added 21.57%	28,501 $1.23 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $177,225 - $194,711	4,726 Added 25.25%	23,444 $996,000
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $720,081 - $820,971	18,718 New	18,718 $817,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Account

Flc Capital Advisors Pfizer Inc Transaction History